Perbedaan Merck Tbk. dan Teladan Prima Agro Tbk.: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Teladan Prima Agro Tbk. diperdagangkan di Rp510 (kapitalisasi pasar 6,6 T, volume 24 jam 512,4 rb). Perbedaan utamanya: Teladan Prima Agro Tbk. jauh lebih besar — sekitar 3,9× kapitalisasi pasar Merck Tbk., dan Teladan Prima Agro Tbk. lebih aktif diperdagangkan (512,4 rb vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | TLDN | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 6,6 T |
Volume | 37,6 rb | 512,4 rb |
Lot | 376 | 5,12 rb |
Perputaran | 144,47 jt | 260,31 jt |
Harga Rata-rata | 3.842,23 | 508,02 |
Nilai Transaksi | 144,47 jt | 260,31 jt |
Harga Ekuilibrium Indikatif | 3.840 | 510 |
Volume Ekuilibrium Indikatif | 7 | 73 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Teladan Prima Agro Tbk ( formerly PT Sandaran Prima Sawit ) was established in the Republic of Indonesia on May 10, 2004 based on the Notarial Deed No. 22 of Imas Fatimah, S.H. On May 25, 2012, the Company's shareholders approved the proposed merger with PT Teladan Agro Resources (“TAR”) where the Company is the recipient of the merger (“Penggabungan 2012”).
Selengkapnya di halaman TLDN →